Login / Signup

ELISPOT assays and their diagnostic potential in Lyme disease and Lyme neuroborreliosis.

N Ettischer-SchmidRosemarie Preyer
Published in: Clinical and experimental immunology (2020)
Keyphrases
  • high throughput
  • human health
  • risk assessment